Republic of the Philippines 
HOUSE OF REPRESENTATIVES 
Quezon City 
NINETEENTH CONGRESS 
First Regular Session 
HOUSE BILL NO. ____ 
Introduced by HON. LUIS RAYMUND “LRAY” F. VILLAFUERTE, JR. 
EXPLANATORY NOTE 
The Constitution, Article XIII, Section 12, provides: 
“The State shall establish and maintain an effective food and drug 
regulatory system and undertake appropriate health manpower 
development and research responsive to the country’s health needs and 
problems.” 
In the United States and other countries, several privately funded voluntary health 
agencies continue to research the possible treatment of dystonia. However, research 
on dystonia in our country remains minimal, or even negligible. 
Not a single treatment is universally effective, and doctors would normally resort to 
therapies to reduce or eliminate muscle spasms and pain that patients suffer. 
This bill seeks to aid and promote research on the causes of dystonia so that they can 
be prevented and that effective treatment can be found. 
In view of the foregoing, approval of this bill is earnestly sought. 
LUIS RAYMUND “LRAY” F. VILLAFUERTE, JR. 
November 10, 2022
2:54 pm
6042


Republic of the Philippines 
HOUSE OF REPRESENTATIVES 
Quezon City 
NINETEENTH CONGRESS 
First Regular Session 
HOUSE BILL NO. ____ 
Introduced by HON. LUIS RAYMUND “LRAY” F. VILLAFUERTE, JR. 
AN ACT 
PROMOTING RESEARCH ON DYSTONIA 
Be it enacted by the Senate and the House of Representatives of the Philippines in 
Congress assembled: 
SECTION 1. Short Title. – This Act shall be known as the “Dystonia Research and 
Information Act.” 
SECTION 2. Declaration of Policy. – The Constitution provides that the State shall 
undertake appropriate health manpower development and research responsive to the 
country’s health needs and problems. Pursuant to this policy, it shall promote 
research for the prevention and treatment on dystonia. 
SECTION 3. Definition of Terms. – For purposes of this Act, the term: 
(A)
“Secretary” shall refer to the Secretary of the Department of Health;
(B)
“Dystonia” shall refer to the movement disorder in which sustained muscle 
contractions cause twisting and repetitive movements or abnormal postures. 
The movements, which are involuntary and sometimes painful, may affect a 
single muscle, a group of muscles, such as those in the arms, legs, or neck, or 
the entire body; and 
(C)
“Committee” refers to the Committee on Dystonia Research.
SECTION 4. Dystonia Research. – The Secretary shall conduct or support research 
6042


 
 
to expand the understanding of dystonia. Such research shall: 
(A) If determined to be scientifically appropriate, include a multidisciplinary, clinical, 
and case-controlled study of dystonia patients; 
 
(B) Involve families of persons who suffer from dystonia, focus on atypical disease 
presentation, neurological dysfunction, diminished intelligence, and emotional 
imbalance; and  
 
(C) Evaluate to what extent, if any, their health differs from other patients with 
neurological disorders. 
 
SECTION 5. Committee on Dystonia Research. – To assist the Secretary in 
receiving accurate and complete information about dystonia, its symptoms, origin, 
classification, prevention, and treatment, there shall be established a committee, to 
be known as the Committee on Dystonia Research, to ensure the strategic 
management, communication, and oversight of the policy formation, research, and 
activities of the government regarding dystonia. 
 
SECTION 6. Composition. – The Committee shall be composed of nine (9) 
members: 
(A) Two (2) representatives from the Department; 
 
(B) One (1) representative of any other agencies necessary to accomplish the 
purpose of the Committee; 
 
(C) Four (4) physicians or practitioners with established credentials in the area of 
neurological disorders; and  
 
(D) Two (2) immediate relatives of dystonia patients to be appointed by the 
Secretary. 
 
The Secretary shall act as chair of the Committee. He shall convene meetings of the 
Committee, not less than twice a year, and compile information for the consideration 
of the full Committee at such meetings. 


 
 
 
SECTION 7. Meetings. – The meetings of the Committee shall be open to the public 
and public witnesses shall be given opportunity to speak and make presentations at 
such meetings. Each member shall make a presentation to the full Committee at each 
meeting concerning the activities conducted by such member. 
 
SECTION 8. Term. – Members shall be appointed by the Secretary for a term of three 
(3) years. Of those first appointed, three (3) members shall serve for three (3) years, 
three (3) members, for two (2) years, and the last three (3) members for one (1) year. 
 
Any vacancy in the membership of the Committee shall be filled in the same manner 
as the original appointment. 
 
Any member of the Committee may be removed for cause in accordance with 
procedures established by the Committee. 
 
SECTION 9. Functions. – The Committee shall have the following functions: 
(A) Advise the Secretary on appropriate research activities to be undertaken by the 
Committee with respect to research on dystonia, its prevention, and treatment; 
 
(B) Report to the Secretary on such research;  
 
(C) Provide recommendations to the Secretary regarding the activities of the 
Committee; 
 
(D) Prepare a report regarding the activities of the Committee; 
 
(E) Ensure that materials concerning dystonia provided by the Department are 
available, up to date, and responsive to reports of problems of dystonia, and that 
timely aggregate data concerning such reports shall be made available to the 
public upon request and consistent with existing confidentiality standards. 
 
SECTION 10. Appropriation. – To carry out the provisions of this Act, such amount 
as may be necessary is hereby authorized to be appropriated from the National 


 
 
Treasury. Thereafter, the amount necessary for the continuous operation of the 
research shall be included in the annual appropriation of the Department of Health. 
 
SECTION 11. Separability Clause. – If any provision or part hereof is held invalid or 
unconstitutional, the remainder of the law or the provision not otherwise affected shall 
remain valid and subsisting. 
 
SECTION 12. Repealing Clause. – Any law, presidential decree or issuance, 
executive order, letter of instruction, administrative order, or rule or regulation contrary 
to or inconsistent with the provisions of this Act is hereby repealed, modified, or 
amended accordingly. 
 
SECTION 13. Effectivity Clause. – This Act shall take effect fifteen (15) days after its 
publication in at least two (2) newspapers of general circulation. 
 
Approved,